![Gregory Ciongoli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Ciongoli
Ordförande på
ATARA BIOTHERAPEUTICS, INC.
Förmögenhet: 13 M $ per 2026-06-30
Profil
Gregory A. Ciongoli is the founder of Adiumentum Capital Management LLC.
Mr. Ciongoli is currently Chairman at Atara Biotherapeutics, Inc. starting in 2025 and Director at Zymeworks, Inc. starting in 2025.
Mr. Ciongoli was a Partner at The Baupost Group LLC.
Mr. Ciongoli earned an MBA from Harvard Business School and completed undergraduate studies at the Woodrow Wilson School of Public & International Affairs.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ZYMEWORKS INC. 0,68 % | 2026-01-12 | 493 500 ( 0,68 % ) | 13 M $ | 2026-06-30 |
| 2026-06-09 | 12 000 ( 0,13 % ) | 137 760 $ | 2026-06-30 |
Aktiva positioner av Gregory Ciongoli
| Företag | Position | Start |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Ordförande | 2025-09-03 |
| ZYMEWORKS INC. | Direktör/Styrelseledamot | 2025-08-11 |
Tidigare kända positioner av Gregory Ciongoli
| Företag | Position | Slut |
|---|---|---|
The Baupost Group LLC
 The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Företagsledare/Principal | - |
Gregory Ciongolis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
4
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
The Baupost Group LLC
The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Woodrow Wilson School of Public & International Affairs
 Woodrow Wilson School of Public & International Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
